pharmaceutical industry and the supply of highly qualified medicines with the most advanced facilities according to KGMP. These efforts has made Hanmi one of the leading and promising pharmaceutical companies in Korea. So, Hanmi has showed continuous annual growth of 20%~30% since its establishment in 1973. And in 2003, its amount of total sales was nearly 243 billion won.
In 2000, all Korean p
pharmaceutical company
We met the vice president of this company, who also in charging of director of sales department. He shows the typical relationship-oriented leader. We asked him that how he put balance between work and relation, he replied that he tried to focus on task. However he was much interested in making relation with his followers than others. Though he is at the high position, he
1. History and introduction of Dong A pharmaceutical
Dong-A Pharmaceutical is the leading pharmaceutical company in Korea. Dong-A stands at the forefront of Korea's pharmaceutical industry; motivated by its respect for life and health to continuously innovate and develop products that enhance people's quality of life. We are working hard to grow internationally and become one of the world's most
pharmaceutical company concentrated on R&Ds, Merck is performing various researches and developments upon medical supplies for human and animals. Merck is providing Pharmaceutical Benefit Management (i.e. PBM) through a company called Merck-Medco Managed Care. Apparently it is a giant pharmaceutical company with more than 15 blockbuster medical supplies, revenue of $3270 million and net profit of
REBATE?
Literally
Paying back a portion of the payment or interest to the payee
In the field of medicine
Pharmaceutical company pays back to the hospital
through negative market
Cause of Rebate in Korea
K-1. Special characteristics of Medical industry
Patients have no option in choice of drugs
Doctors have the incentive to use their
professionalism to maximize their p